How Quantum Computing will Impact Healthcare

Developing pharmaceuticals through lengthy and costly clinical trials is definitely an approach which is here since long.

Zydus to supply product to US company Sagent from Gujarat plant

Zydus Lifesciences announced that it will be producing and supplying Sagent’s caffeine citrate oral solution in the strength of 60 mg per 3 mL (20 mg per mL) Single-dose Vial (US RLD: CAFCIT) from its injectables facility at Jarod, Gujarat.

Lupin to hire talent in digital health, diagnostics, data science

Pharmaceutical major Lupin is looking to step up its presence in India, with its hiring connected to new business divisions being launched.

Aleor Dermaceuticals, Lidocaine, and Prilocaine topical cream is approved by the US Food and Drug Administration

Alembic Pharmaceuticals Limited (Alembic) today declared its wholly-owned subsidiary, Aleor Dermaceuticals Limited (Aleor) has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application

Britain broadens access to Pfizer's COVID antiviral drug through trial

Britain will increase access to Pfizer's oral antiviral COVID-19 treatment to thousands more people by adding it to a trial to assess how best to use the drug in its highly vaccinated population, the health ministry said on Tuesday

Moderna appoints Jorge Gomez as CFO

Moderna Inc on Monday named Jorge Gomez, a senior executive at dental products maker Dentsply Sirona Inc, as its new chief financial officer, effective May 9

Pfizer hires David Denton, formerly of Lowe's, as CFO

Pfizer Inc said on Monday that Lowe’s Cos Inc Chief Financial Officer David Denton would succeed the company

Abbott unveils Arachitol Gummies in India

Healthcare major Abbott on Monday said it has launched Arachitol Gummies in India, a dietary supplement that helps maintain required levels of Vitamin D sustainably.Launched in orange fruit flavour, the gummies are approved as health supplements by t

Glenmark gets DCGI nod to conduct clinical trials of its molecule on cancer patients

Glenmark Pharmaceuticals on Monday said its unit has received approval from the Drug Controller General of India (DCGI) to conduct phase 1 clinical trials of its novel molecule on patients with advanced solid tumors. Glenmark Specialty SA has receive

Torrent, JB Chemicals in final race to buy Curatio Healthcare

Torrent Pharmaceuticals and KKR-controlled JB Chemicals are among the final contenders to acquire Chennai-based Curatio Healthcare for about ₹2,500 crore in what could be the continuation of M&A deals in the pharma and life sciences space. Torrent Ph

© 2025 India Pharma Outlook. All Rights Reserved.